Sample collection and use for research purposes were approved by the Institutional Review Board of CHA General Hospital, Seoul, Korea. All participants provided written informed consent prior to sample collection. The placentas were collected from female subjects who were free of medical, obstetric and surgical complications and who delivered at term (>37 gestational weeks). The CP-MSCs were harvested as previously described (22 (
link)). Briefly, the CP-MSCs were collected from the inner side of the chorioamniotic membrane of the placenta and treated with 0.5%
collagenase IV (C7661; Sigma-Aldrich, St. Louis, MO, USA) and cultured in
MEM-α modification (#32561; Gibco-BRL, NY, USA) supplemented with 10%
fetal bovine serum (FBS, #16000-044), 1%
penicillin/streptomycin (#15140-122) (all from Invitrogen, Carlsbad, CA, USA), 25 ng/ml human fibroblast growth factor-4 (
hFGF-4; #AF-100-31; Peprotech, Inc., Rocky Hill, NJ, USA) and 1
µg/ml
heparin (H3149; Sigma-Aldrich).
In addition, the normal fibroblast cell line,
WI-38, was purchased from ATCC (#CCL-75, ATCC; Manassas, VA, USA). The cells were cultured in α-MEM containing 10% FBS, 1%
penicillin/streptomycin (P/S; 100 mg/ml, Gibco-BRL), and 2 mM
L-glutamine (Gibco-BRL).
CHUNG S., RHO S., KIM G., KIM S.R., BAEK K.H., KANG M, & LEW H. (2016). Human umbilical cord blood mononuclear cells and chorionic plate-derived mesenchymal stem cells promote axon survival in a rat model of optic nerve crush injury. International Journal of Molecular Medicine, 37(5), 1170-1180.